WO2022224146A1 - Brassica napus line ome0001 - Google Patents
Brassica napus line ome0001 Download PDFInfo
- Publication number
- WO2022224146A1 WO2022224146A1 PCT/IB2022/053662 IB2022053662W WO2022224146A1 WO 2022224146 A1 WO2022224146 A1 WO 2022224146A1 IB 2022053662 W IB2022053662 W IB 2022053662W WO 2022224146 A1 WO2022224146 A1 WO 2022224146A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seed
- plant
- line
- canola
- brassica
- Prior art date
Links
- 240000002791 Brassica napus Species 0.000 title claims abstract description 43
- 235000011293 Brassica napus Nutrition 0.000 title claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims abstract description 114
- 238000000034 method Methods 0.000 claims abstract description 61
- 241000219198 Brassica Species 0.000 claims abstract description 51
- 240000000385 Brassica napus var. napus Species 0.000 claims abstract description 45
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims abstract description 37
- 235000006008 Brassica napus var napus Nutrition 0.000 claims abstract description 34
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims abstract description 32
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims abstract description 32
- 235000011331 Brassica Nutrition 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 238000009395 breeding Methods 0.000 claims abstract description 19
- 108700019146 Transgenes Proteins 0.000 claims abstract description 18
- 230000001488 breeding effect Effects 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 230000009261 transgenic effect Effects 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 46
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- 239000000194 fatty acid Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 15
- 235000019198 oils Nutrition 0.000 claims description 15
- 235000012054 meals Nutrition 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 10
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 10
- 230000000877 morphologic effect Effects 0.000 claims description 6
- 208000035240 Disease Resistance Diseases 0.000 claims description 5
- 241000238631 Hexapoda Species 0.000 claims description 5
- 230000002363 herbicidal effect Effects 0.000 claims description 5
- 239000004009 herbicide Substances 0.000 claims description 5
- 208000035143 Bacterial infection Diseases 0.000 claims description 4
- 208000031888 Mycoses Diseases 0.000 claims description 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 3
- 244000178993 Brassica juncea Species 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000000828 canola oil Substances 0.000 claims description 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019519 canola oil Nutrition 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 claims description 2
- 238000012239 gene modification Methods 0.000 claims description 2
- 230000010152 pollination Effects 0.000 claims description 2
- 210000001938 protoplast Anatomy 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 6
- 230000036512 infertility Effects 0.000 claims 3
- 238000009360 aquaculture Methods 0.000 claims 2
- 244000144974 aquaculture Species 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 230000008635 plant growth Effects 0.000 claims 2
- 240000008415 Lactuca sativa Species 0.000 claims 1
- 230000001276 controlling effect Effects 0.000 claims 1
- 239000008162 cooking oil Substances 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 231100000219 mutagenic Toxicity 0.000 claims 1
- 230000003505 mutagenic effect Effects 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 235000012045 salad Nutrition 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 description 9
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 244000060924 Brassica campestris Species 0.000 description 5
- 108091092878 Microsatellite Proteins 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 125000004383 glucosinolate group Chemical group 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 5
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 4
- 230000035558 fertility Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- -1 2-hydroxy-3 butenyl Chemical group 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 241000219193 Brassicaceae Species 0.000 description 3
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000010432 diamond Substances 0.000 description 3
- 229910003460 diamond Inorganic materials 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- 101100049754 Archaeoglobus fulgidus (strain ATCC 49558 / DSM 4304 / JCM 9628 / NBRC 100126 / VC-16) wtpB gene Proteins 0.000 description 2
- 101100457845 Azotobacter vinelandii modA gene Proteins 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- 241000825199 Rebecca salina Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000004129 fatty acid metabolism Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000020667 long-chain omega-3 fatty acid Nutrition 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 101150033385 modB gene Proteins 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 101710124165 1-acyl-sn-glycerol-3-phosphate acyltransferase Proteins 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- 108010011619 6-Phytase Proteins 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241001163841 Albugo ipomoeae-panduratae Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 244000257790 Brassica carinata Species 0.000 description 1
- 244000178924 Brassica napobrassica Species 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- XMJFVIGTHMOGNZ-NSUIRHMESA-N Glucobrassicanapin Natural products S(=O)(=O)(O/N=C(/S[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)\CCCC=C)O XMJFVIGTHMOGNZ-NSUIRHMESA-N 0.000 description 1
- NCWFGOSXGPNCHQ-KAMPLNKDSA-N Gluconapin Natural products OC[C@H]1O[C@H](SC=NCCC=C)[C@H](O)[C@@H](O)[C@@H]1O NCWFGOSXGPNCHQ-KAMPLNKDSA-N 0.000 description 1
- ZEGLQSKFSKZGRO-IJSGRZKHSA-N Gluconapoleiferin Natural products OC[C@H]1O[C@@H](SC(=NOS(=O)(=O)O)C[C@H](O)CC=C)[C@H](O)[C@@H](O)[C@@H]1O ZEGLQSKFSKZGRO-IJSGRZKHSA-N 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 101710097496 Lysophospholipid acyltransferase Proteins 0.000 description 1
- 101710163746 Lysophospholipid acyltransferase 2 Proteins 0.000 description 1
- 102100038805 Lysophospholipid acyltransferase 2 Human genes 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241001536507 Micromonas pusilla Species 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- 101710172946 Probable 1-acyl-sn-glycerol-3-phosphate acyltransferase Proteins 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 241001555186 Pyramimonas cordata Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- ZEGLQSKFSKZGRO-RELRXRRDSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3s)-3-hydroxy-n-sulfooxyhex-5-enimidothioate Chemical compound OC[C@H]1O[C@@H](SC(C[C@@H](O)CC=C)=NOS(O)(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O ZEGLQSKFSKZGRO-RELRXRRDSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- XMJFVIGTHMOGNZ-AHMUMSBHSA-N glucobrassicanapin Chemical compound OC[C@H]1O[C@@H](S\C(CCCC=C)=N/OS(O)(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O XMJFVIGTHMOGNZ-AHMUMSBHSA-N 0.000 description 1
- PLYQBXHVYUJNQB-IIPHORNXSA-N gluconapin Chemical compound OC[C@H]1O[C@@H](S\C(CCC=C)=N/OS(O)(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O PLYQBXHVYUJNQB-IIPHORNXSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108010018154 inositol 1-alpha-galactosyltransferase Proteins 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000009403 interspecific hybridization Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/10—Seeds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/10—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits
- A01H1/101—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine
- A01H1/104—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/20—Brassicaceae, e.g. canola, broccoli or rucola
- A01H6/202—Brassica napus [canola]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/008—Methods for regeneration to complete plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
- C12N15/8289—Male sterility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/14—Plant cells
Definitions
- the present embodiments relate to a new and distinctive DHA-producing Bras sica napus line designated OME0001
- co3 LC PUFA Long-chain omega-3 polyunsaturated fatty acids
- co3 LC PUFA (4Z,7Z,10Z,13Z,16Z,19Z)- docosa-4,7,10,13,16,19-hexaenoic acid (DHA) is a primary structural component of the human brain, cerebral cortex, skin, and retina. There remains a need for land-based sources of co3 LC PUFA including DHA.
- the present embodiments provide a plant, derivative or progeny plant, plant part, or seed of DHA Brassica napus line OME0001 (“DHA Canola OME0001”), representative sample of seed of which was deposited under ATCC Accession No. PTA-126906 (see Appendix).
- Line OME0001 produces DHA and other long chain omega 3 polyunsaturated fatty acids in its seed oil.
- One aspect of the present embodiments provides a method for producing a DHA Canola seed comprising crossing two Brassica plants and harvesting the resultant seed, wherein at least one of the two Brassica plants is DHA Canola line OME0001 or progeny thereof.
- Another aspect of the present embodiments provides methods of producing co3
- LC PUFA comprising DHA from DHA Canola OME0001.
- the present embodiments provide for Brassica lines that produces the LC co3 PUFA DHA in its seed oil, specifically a line embodying the trait of B. napus line OME0001.
- LC co3 PUFAs are known in the art and for a relevant discussion of these and other fatty acids, see e.g., WO 2017/218969 and WO 2017/219006.
- Brassica napus belongs to the Cruciferae ( Brassicaceae ) plant family, typically referred to as rapeseed or canola. More specifically, rapeseed ( Brassica napus subsp. napus) is a bright-yellow flowering member of the family Brassicaceae (mustard or cabbage family), cultivated mainly for its oil-rich seed. Rapeseed is the third-largest source of vegetable oil and second-largest source of protein meal in the world. Rapeseed oil that often contains appreciable amounts of toxic erucic acid, however, rendering the oil inedible.
- Canola are a group of rapeseed cultivars that were bred to have very low levels of erucic acid and are especially prized for use for human and animal food. More specifically, “canola oil” must contain less than 2% erucic acid; and canola meal is defined as one gram of air-dry, oil-free meal that must contain less than 30 pmoles of 3-butenyl glucosinolate, 4-pentenyl glucosinolate, 2-hydroxy-3 butenyl glucosinolate, 2-hydroxy-4-pentenyl glucosinolate, or a mixture thereof. See, e.g..
- Brassica napus is a digenomic amphidiploid resulting from interspecific hybridization between Brassica oleracea and Brassica rapa. It is a self-compatible pollinating species like the other amphidiploid brassica species. Notably, wild-type B. napus does not produced DHA or other very long chain PUFA in seed oil.
- a “line” is a group of plants that displays very little overall variation among individuals sharing that designation. “Line” also refers to a homogeneous assemblage of plants carrying substantially the same genetic material that display little or no genetic variation between individuals for at least one trait, , in particular the transgenes present in line OME0001. “Variety” or “cultivar” may be used interchangeably with “line,” but in general the former two terms refer to a line that is suitable for commercial production.
- Genetically derived as used for example in the phrase “genetically derived from the parent lines” means that the characteristic in question is dictated wholly or in part by an aspect of the genetic makeup of the plant in question.
- Progeny means all descendants including offspring and derivatives of a plant or plants and includes the first, second, third, and subsequent generations; and may be produced by self-pollination or crossing with plants with the same or different genotypes, and may be modified by a range of suitable genetic engineering techniques.
- Cultigen generally relates to plants that have been deliberately altered and selected by human.
- TO refers to the first generation of transformed plant material
- Tl refers to the seed produced on TO plants
- T1 seed gives rise to Tl plants that produce T2 seed, etc., to subsequent Tx progeny.
- “Breeding” includes all methods of developing or propagating plants and includes both intra- and inter-species and into- and inter-line crosses as well as all suitable conventional breeding and artificial breeding techniques. Desired traits (e.g., the OME0001 DHA trait) may be transferred to other canola or B. napus lines, cultivars, or cultigens; or through conventional breeding methods and can also be transferred to other Brassica species, such as B. rapa, through inter-specific crossing. Both conventional breeding methods and inter specific crossing methods, as well as other methods of transferring genetic material between plants, are well-known in the art. For pure line selection, the progeny of single plant selections (self-pollinated), are kept separate and not bulked together. The expected result is a set of genetically homogeneous lines. Accordingly, a pure line may be the progeny of a single self- fertilized homozygous plant.
- Desired traits e.g., the OME0001 DHA trait
- B. napus lines cultivars
- Plant part includes plant cells, plant organs, plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clumps, and plant cells that are intact in plants or parts of plants such as embryos, pollen, ovules, seeds, pods, leaves, flowers, branches, fruit, stalks, roots, root tips, anthers, cotyledons, hypocotyls, radicles, single cells, gametes, cell cultures, tissue cultures, and the like.
- a cotyledon is a type of seed leaf; a small leaf contained on a plant embryo.
- a cotyledon contains the food storage tissues of the seed. The embryo is a small plant contained within a mature seed.
- Plant cells also encompasses non- regenerable plant cells. Accordingly, the embodiments include plants and plant parts from line OMEOOOl line, as well as other plants produced by the described methods. Progeny, derivatives, variants, and mutants of regenerated plants are also included within the scope of the present embodiments, provided that these parts comprise event OMEOOOl nucleic acid molecules. The present embodiments are also directed to line OMEOOOl transgenes, and to their use, e.g., in plant cell culture and tissue culture, and for methods of identifying line OMEOOO 1. The embodiments include plants and plant parts from the elite event OMEOOO 1 line, as well as other plants produced by the described methods. Progeny, derivatives, variants, and mutants of regenerated plants are also included within the scope of the present embodiments, provided that these parts comprise event OMEOOOl nucleic acid molecules.
- At least one embodiment described herein provides a new B. napus line, designated OMEOOOl (DHA Canola OMEOOOl), that produces DHA in its seed oil.
- OMEOOOl DHA Canola OMEOOOl
- Other aspects of the present embodiments provide seed, plants, and plant parts of DHA Canola OMEOOOl; progeny of OMEOOOl; methods for producing a canola plant produced by crossing the DHA Canola OMEOOOl with itself or another canola genotype; and the creation of variants by mutagenesis or transformation of DHA Canola OMEOOOl.
- the present embodiments include any such methods using the line OMEOOOl, including selfing, backcrossing, hybrid production, and crosses to populations.
- DHA Canola OMEOOOl is used in crosses with other different canola plants to produce first generation (Fi) hybrid seeds and plants with superior characteristics.
- members of the Brassica genus useful in practicing the present embodiments include but are not limited to B. napus, B. napobrassica, B. oleracea, B. carinata, B. rapa,
- seed plant refers to any one of the species B. napus, B. rapa (or campestris), or B. juncea.
- DHA Canola OMEOOOl is open pollinated, produces medium to tall sized plants, flowers mid-season, and matures early. Plants have high early plant vigor, are branched, and produce long pods.
- the seed of OMEOOOl contains co3 LC PUFA including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) characteristic of the Omega 3 NS-B500274 trait, and low saturated and erucic fatty acid content, and low glucosinolate content characteristic of Canola.
- EPA eicosapentaenoic acid
- DPA docosapentaenoic acid
- DHA docosahexaenoic acid
- Phenotypic characterizations of DHA Canola OMEOOOl, in addition to production of DHA in seed oil include:
- the DHA Canola OMEOOOl provided herein is a B-line.
- DHA Canola derived from OMEOOOl may be an A-line, a B-line, or a R-line.
- An A-line is an Ogura cytoplasmic male sterile line (CMS).
- CMS Ogura cytoplasmic male sterile line
- a B-line is similar to an A-line in all features, but it is a male fertile version (a line of similar nuclear genotype but carrying a male fertile cytoplasm).
- a R-line (Ogura Rf) carries male sterile cytoplasm but is fixed for a nuclear restorer factors and restores fertility and is used to produce an FI hybrid seed.
- a restorer line is a pollinator variety used to pollinate a CMS or A-line to produce FI progeny which are male fertile and thus produce seeds on selfing.
- An inbred line may permit restoration of fertility to the progeny of male sterile lines to which it is crossed.
- hybrid lines may be grown from FI seed produced by crossing two inbred (pure) lines, one of which may be male sterile.
- OMEOOOl being a B-line, can be grown as an open pollinated variety or used in the Ogura system to produce FI hybrid variety.
- the present embodiments provide a method of introducing a desired trait into DHA Canola line OMEOOOl, wherein the method comprises crossing an OMEOOOl plant with a plant of another Brassica genotype that comprises a desired trait to produce progeny plants, wherein the desired trait is selected from the group consisting of male sterility, herbicide tolerance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism, modified seed yield, modified oil percent, modified protein percent, modified lodging resistance, and resistance to bacterial disease, fungal disease, or viral disease; selecting one or more progeny plants that have the desired trait to produce selected progeny plants; crossing the selected progeny plants with the OMEOOOl plants to produce backcross progeny plants; selecting for backcross progeny plants that have the desired trait and essentially all of the physiological and morphological characteristics of the OME0001 line to produce selected backcross progeny plants; and repeating these steps three or more times to produce selected fourth or higher backcross progeny plants that comprise the desired trait and essentially
- Line OMEOOOl was bred from parental line B. napus, NS-B50027-4, which was developed by Agrobacterium tumefaciens -mediated transformation with the genetic construct pJP3416_GA7-modB (“modB”), that includes seven genes capable of promoting the accumulation of co3 fatty acids in seed. See Petrie et al., Development of a Brassica napus (Canola) Crop Containing Fish Oil-Like Levels ofDHA in the Seed Oil, 11 Frontiers Plant Sci.
- the modB construct contains genes encoding a D ⁇ -dcsaturasc cloned from the microalga Micromonas pusilla, a D ⁇ -elongase and a A5-elongase cloned from the microalga Pyramimonas cordata, a A5-desaturase cloned from the microalga Pavlova salina, a D 15/o)3-desaturase cloned from the yeast Pichia pastoris, a D 12-desaturase cloned from the yeast Lachancea kluyveri, and a A4-desaturase cloned from Pavlova salina, each with suitable transcription promoters and terminators to provide expression in seed.
- Line OMEOOOl was bred from an advanced breeding line NX 140, a parental line developed by Nuseed via a pedigree and recurrent selection based breeding program that included a complex crossing using Nuseed Canola Genetic Resources and targeted selection strategy using field nurseries to combine: high grain yield potential, traits that provide general agronomic adaptation (e.g., spring type canola, aerial branching habit, and pod set characteristics), blackleg disease resistance, and a canola quality seed oil profile.
- traits that provide general agronomic adaptation e.g., spring type canola, aerial branching habit, and pod set characteristics
- blackleg disease resistance e.g., blackleg disease resistance
- the DHA canola line OME0001 was derived from a marker assisted backcross (BC) program were the “final cross” was from the third cross between NX0140 and NS-B50027-4.
- BC3F2 generation plants homozygous for NS-B50027-4 event construct inserts were identified using molecular markers.
- OMEOOOl was derived from BC3F2 seed from and individual F2 plant. Reselection was undertaken in the glasshouse and in single row progeny experimental trials to F4 generation. At each cycle, single plant selections were bagged with a perforated plastic bag prior to flowering and then selfed.
- the optimal sib genotypes were advanced on the basis of fatty acid profile (e.g., LC PUFA %, specifically DHA% as a % of total fatty acids in the seed), agronomic traits (e.g., vigor, fertility, standability, blackleg disease tolerance, oil content, maturity, flowering time, plant and pod structures) and other seed quality traits (e.g., seed oil %).
- fatty acid profile e.g., LC PUFA %, specifically DHA% as a % of total fatty acids in the seed
- agronomic traits e.g., vigor, fertility, standability, blackleg disease tolerance, oil content, maturity, flowering time, plant and pod structures
- other seed quality traits e.g., seed oil %.
- the BC3-derived F4 selection was tested in replicated field experiments from 2018 for grain yield, agronomic traits, fatty acid profile, and seed oil traits (e.g., seed oil%). Based on this assessment,
- OMEOOOl is thus a transgenic Brassica that is genetically stable, uniform, and no off-type plants have been exhibited in evaluation.
- the OMEOOOl line has shown genetic stability and uniformity as described in the phenotypic description information. The line has been increased with continued observation for uniformity. Accordingly, an embodiment provides a seed of B. napus line designated OMEOOOl, a representative sample of seed of which was deposited under ATCC Accession No. PTA-126906.
- the primary phenotypic characteristic of OMEOOO 1 is the production of noticeable amounts of DHA in its seed oil. As shown herein, the bulk seed of OMEOOOl typically contains about 7.5% DHA (as % of total fatty acids in seed), or more.
- At least one embodiment is directed to methods for producing a DHA Canola Brassica plant by crossing a first parent plant with a second parent plant, wherein the first or second plant is the plant from the Brassica line OMEOOO 1.
- both first and second parent plants may be from the line OMEOOO 1. Any breeding methods using the line OMEOOOl are envisioned: selfing, backcrosses, hybrid breeding, and crosses to populations.
- Additional methods of the present embodiments include introduction of expression vectors introduced into plant tissues using a direct gene transfer method such as microprojectile-mediated delivery, DNA injection, electroporation or by using Agrobacterium- mediated transformation.
- a transgenic variant of OMEOOOl may contain at least one additional transgene (in addition to those present in OMEOOOl), such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 additional transgenes.
- the present invention also relates to super- transformed variants of the claimed line OMEOOOl, or variants obtained by breeding OMEOOOl with one or more other transgenic Brassica.
- transgenes are expressed under control of regulatory sequences (e.g., promoters, enhancers, intervening sequences, terminators) well- known in the art.
- regulatory sequences e.g., promoters, enhancers, intervening sequences, terminators
- the desired trait may be one or more of herbicide tolerance, insect resistance, disease resistance, modified seed yield, modified oil percent, modified protein percent, modified lodging resistance, or modified fatty acid or carbohydrate metabolism.
- the specific gene may be any gene known in the art or listed herein, including but not limited to a marker gene, a polynucleotide (nucleic acid molecule) conferring resistance or tolerance to imidazolinone, sulfonylurea, glyphosate, glufosinate, 2,4-D, Dicamba, L- phosphinothricin, triazine, hydroxyphenylpyruvate dioxygenase inhibitor, protoporphyrinogen oxidase inhibitor, phenoxy proprionic acid, cyclohexone, or benzonitrile; a polynucleotide encoding a Bacillus thuringiensis polypeptide, a polynucleotide encoding phytase, a polynucleotide encoding a 1 -acyl-glycerol-3 -phosphate acyltransferase (LPAAT), a galactinol syntha
- transgenes and related techniques are well- known in the art, see, e.g.. U.S. Patents No. 9,718,759, No. 8,143,488.
- the DHA trait of such transgenic embodiments may be obtained by breeding a canola comprising at least one transgene with OMEOOO 1.
- the trait of producing DPA as well as DHA may be obtained by introgressing chromosomes from DPA JunceaNUBJ1207 (see W02021041570) into OMEOOO 1.
- transgenes or other phenotypic traits can be introduced into OMEOOO 1 or the DHA-producing trait of OMEOOO 1 introduced into other Brassica or canola lines using traditional breeding techniques, such as introgression or backcrossing, well-known in the art.
- Canola plant breeding techniques that may be employed in generating progeny of OMEOOO 1 include, for example, recurrent selection, bulk selection, mass selection, mutation breeding, backcrossing, pedigree breeding, tissue culture, open pollination breeding, restriction fragment length polymorphism enhanced selection, genetic marker enhanced selection, producing doubled haploids. Often combinations of these techniques are used.
- the development of Brassica varieties in a plant breeding program requires, in general, the development and evaluation of homozygous varieties.
- OMEOOO 1 and its progeny can be identified not only by its phenotypic trait (i.e., production of DHA), but by identification of its genotype.
- Methods and kits are useful for identifying in biological samples the presence of plant material comprising specifically the transgenes in DHA Canola OMEOOO 1, as well as transgenic Brassica plants, plant materials, and seeds containing such event.
- the elite event DHA Canola OMEOOO 1 described herein can be identified by genotype, which can be characterized through a genetic marker profile that can identify plants of the same cultivar or a related cultivar or be used to determine or validate a pedigree.
- Genetic marker profiles can be obtained by techniques such as Restriction Fragment Length Polymorphisms (RFLP), Randomly Amplified Polymorphic DNAs (RAPD), Arbitrarily Primed Polymerase Chain Reaction (AP-PCR), DNA Amplification Fingerprinting (DAF), Sequence Characterized Amplified Regions (SCAR), Amplified Fragment Length Polymorphisms (AFLP), Simple Sequence Repeats (SSR) (also referred to as Microsatellites), and Single Nucleotide Polymorphisms (SNP).
- RFLP Restriction Fragment Length Polymorphisms
- RAPD Randomly Amplified Polymorphic DNAs
- AP-PCR Arbitrarily Primed Polymerase Chain Reaction
- DAF Sequence Characterized Amplified Regions
- AFLP Amplified Fragment Length Polymorphisms
- SSR Simple Sequence Repeats
- SNP Single Nucleotide Polymorphisms
- the DHA Canola OMEOOO 1 described herein can be identified by generation of a genetic map from a sample of plant material.
- a genetic map can be generated by conventional RFLP, Polymerase Chain Reaction (PCR) analysis, or SSR which identifies the approximate chromosomal location of the integrated DNA molecule coding for the foreign protein. See Glick & Thompson, METHODS IN PLANT MOLEC. BIOL. & BIOTECHNOL. (CRC Press, Boca Raton, 1993). Map information concerning chromosomal location is useful for proprietary protection of a subject transgenic plant. For example, the map of the integration region can be compared to similar maps for suspect plants to determine if the latter have a common parentage with the subject plant. Map comparisons can involve hybridizations, RFLP, PCR, SSR and sequencing, all of which are conventional techniques.
- primers to identify the junctions can be any suitable length derived from a larger junction sequence.
- the length of the junction sequences used to identify DEIA Canola OMEOOO 1 may be any suitable length that provides identification of a unique junction.
- Canola is recognized as an increasingly important oilseed crop and a source of meal in many parts of the world.
- DEIA Canola line OMEOOO 1 or its progeny can be used in the production of oil, meal, or other food or feed products in accordance with known techniques.
- DHA Canola OMEOOO 1 was field trialed in replicated plot experiments in 2018, in the South West (Location A) and Wimmera (location B) cereal and broadleaf cropping zones of Victoria, Australia. These cropping zones are characterized by autumn sowing, winter dominant rainfall (i.e., Mediterranean-like) and basalt based acid sodosols for location A, and clay black cracking alkaline vertosols soils for location B. Seed obtained from OMEOOO 1 had the following fatty acid profile as determined by gas chromatography (Table 2):
- DHA-producing B. napus line OMEOOO 1 was grown at two test sites in Canada in 2018, in Canadian plant hardiness zone 3A (Saskatchewan); and the data on oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 5:
- B. napus line OMEOOO 1 was grown in Australian plot experiments in 2019, in two locations in the Wimmera cropping zone described above. Seed obtained from OMEOOO 1 had the following fatty acid profde as determined by gas chromatography as shown in Table 6:
- line OMEOOO 1 pooled seed contained 7.88% total saturated fatty acid. Additional data on yield, oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 7 :
- DHA-producing B. napus line OMEOOO 1 was field tested at two sites in Canada in 2019, and the data on grain yield, oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 9:
- DHA-producing B. napus line OMEOOO 1 was field trialed with comparators at two sites in Canada (Site A, zones 3a; and Site B, zones 3b, respectively) and two sites in the United States (C and D, each zone 4a) in 2019.
- the mean grain yield across all four sites was 2.10 t/ha.
- the amount of DHA (as area %) produced by DHA Canola OMEOOO 1 ranged from 5.5% DHA to 8.6% DHA, and the mean across the sites was 7.0% DHA. Further yield at the two Canadian sites is shown in Table 10:
- DHA-producing B. napus line OMEOOO 1 was field trialed with comparators at two sites in the United States (Sites E and F), one site in Canada (Site G), and two sites in Australia (Sites H and I) in 2020.
- the seed content for the 2020 experiment are presented in Table 13.
- DHA-producing B. napus line OMEOOOl was field trialed with NS-B50027-4 as a comparator at four sites in Canada (Sites J, K, L, and M), one site in the United States (Site N), and two sites in Australia (Sites O and P) in 2021.
Abstract
The present embodiments provide a novel DHA-producing Brassica napus line designated as OME0001 (DHA Canola OME0001). The embodiments also provide the seeds, the plants, and the plant parts (including DNA) of DHA Canola line OME0001, as well as to methods for producing a Brassica plant produced by crossing DHA Canola line OME0001 with itself or another Brassica line. These embodiments also provide methods for producing a DHA-producing Brassica plant containing in its genetic material one or more transgenes, and to the transgenic plants and plant parts produced by those methods. These embodiments further provide DHA production lines or breeding lines and plant parts derived from DHA Canola line OME0001, to methods for producing canola lines or plant parts derived from line OME0001, and to the DHA-producing Brassica plants, varieties, and their parts derived from use of those methods. These embodiments also provide hybrid seeds, plants, and plant parts produced by crossing the DHA Canola line OME0001 with another Brassica or canola line.
Description
Brassica napus Line OME0001
RELATED APPLICATION
[0001] This Application claims priority benefit of U.S. Provisional Application
No. 63/176,991 filed 20 April 2021, which is incorporated fully herein for all purposes.
FIELD
[0002] The present embodiments relate to a new and distinctive DHA-producing Bras sica napus line designated OME0001
BACKGROUND
[0003] Long-chain omega-3 polyunsaturated fatty acids (co3 LC PUFA) are well recognized for their critical role in human diets. The co3 LC PUFA (4Z,7Z,10Z,13Z,16Z,19Z)- docosa-4,7,10,13,16,19-hexaenoic acid (DHA) is a primary structural component of the human brain, cerebral cortex, skin, and retina. There remains a need for land-based sources of co3 LC PUFA including DHA.
SUMMARY
[0004] The present embodiments provide a plant, derivative or progeny plant, plant part, or seed of DHA Brassica napus line OME0001 (“DHA Canola OME0001”), representative sample of seed of which was deposited under ATCC Accession No. PTA-126906 (see Appendix). Line OME0001 produces DHA and other long chain omega 3 polyunsaturated fatty acids in its seed oil.
[0005] One aspect of the present embodiments provides a method for producing a DHA Canola seed comprising crossing two Brassica plants and harvesting the resultant seed, wherein at least one of the two Brassica plants is DHA Canola line OME0001 or progeny thereof.
[0006] Another aspect of the present embodiments provides methods of producing co3
LC PUFA comprising DHA from DHA Canola OME0001.
DETAILED DESCRIPTION
[0007] It should be understood that this invention is not limited to the particular methodology, protocols, and reagents, etc., described herein and as such may vary. The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention, which is defined solely by the claims.
[0008] All patents and other publications identified are incorporated herein by reference for the purpose of describing and disclosing, for example, the methodologies described in such publications that might be used in connection with the present invention, but are not to provide definitions of terms inconsistent with those presented herein. These publications are provided solely for their disclosure prior to the filing date of the present application. Nothing in this regard should be construed as an admission that the inventors are not entitled to antedate such disclosure by virtue of prior invention or for any other reason. All statements as to the date or representation as to the contents of these documents is based on information available to the applicants and do not constitute any admission as to the correctness of the dates or contents of these documents.
[0009] As used herein and in the claims, the singular forms “a,” “an,” and “the” include the plural reference unless the context clearly indicates otherwise. Throughout this specification, unless otherwise indicated, “comprise,” “comprises,” and “comprising” are used inclusively rather than exclusively, so that a stated integer or group of integers may include one or more other non-stated integers or groups of integers. The term “or” is inclusive unless modified, for example, by “either.” Thus, unless context indicates otherwise, the word “or” means any one member of a particular list and also includes any combination of members of that list.
[0010] All values are approximate as there is some fluctuation in fatty acid composition due to environmental conditions. Values are typically expressed as area percent, which approximates percent by weight, of total fatty acid or percent weight of the total seed. Accordingly, other than in the operating examples, or where otherwise indicated, all numbers expressing quantities or reaction conditions used herein should be understood as modified in all instances by the term “about.”
[0011] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as those commonly understood to one of ordinary skill in the art. The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention, which is defined solely by the claims. In order that the present disclosure can be more readily understood, certain terms are first defined. Additional definitions are set forth throughout the detailed description.
[0012] The present embodiments provide for Brassica lines that produces the LC co3 PUFA DHA in its seed oil, specifically a line embodying the trait of B. napus line OME0001. LC co3 PUFAs are known in the art and for a relevant discussion of these and other fatty acids, see e.g., WO 2017/218969 and WO 2017/219006.
[0013] Brassica napus belongs to the Cruciferae ( Brassicaceae ) plant family, typically referred to as rapeseed or canola. More specifically, rapeseed ( Brassica napus subsp. napus) is a
bright-yellow flowering member of the family Brassicaceae (mustard or cabbage family), cultivated mainly for its oil-rich seed. Rapeseed is the third-largest source of vegetable oil and second-largest source of protein meal in the world. Rapeseed oil that often contains appreciable amounts of toxic erucic acid, however, rendering the oil inedible. Canola are a group of rapeseed cultivars that were bred to have very low levels of erucic acid and are especially prized for use for human and animal food. More specifically, “canola oil” must contain less than 2% erucic acid; and canola meal is defined as one gram of air-dry, oil-free meal that must contain less than 30 pmoles of 3-butenyl glucosinolate, 4-pentenyl glucosinolate, 2-hydroxy-3 butenyl glucosinolate, 2-hydroxy-4-pentenyl glucosinolate, or a mixture thereof. See, e.g.. CODEX ALIMENTARIUS: FATS, OILS & RELATED PRODUCTS, Vol. 8 (2nd ed., Food & Agriculture Org. United Nations, Rome, Italy, 2001). Brassica napus is a digenomic amphidiploid resulting from interspecific hybridization between Brassica oleracea and Brassica rapa. It is a self-compatible pollinating species like the other amphidiploid brassica species. Notably, wild-type B. napus does not produced DHA or other very long chain PUFA in seed oil.
[0014] A “line” is a group of plants that displays very little overall variation among individuals sharing that designation. “Line” also refers to a homogeneous assemblage of plants carrying substantially the same genetic material that display little or no genetic variation between individuals for at least one trait, , in particular the transgenes present in line OME0001. “Variety” or “cultivar” may be used interchangeably with “line,” but in general the former two terms refer to a line that is suitable for commercial production.
[0015] “Genetically derived” as used for example in the phrase “genetically derived from the parent lines” means that the characteristic in question is dictated wholly or in part by an aspect of the genetic makeup of the plant in question.
[0016] “Progeny” means all descendants including offspring and derivatives of a plant or plants and includes the first, second, third, and subsequent generations; and may be produced by self-pollination or crossing with plants with the same or different genotypes, and may be modified by a range of suitable genetic engineering techniques. Cultigen generally relates to plants that have been deliberately altered and selected by human. “TO” refers to the first generation of transformed plant material, “Tl” refers to the seed produced on TO plants, T1 seed gives rise to Tl plants that produce T2 seed, etc., to subsequent Tx progeny.
[0017] “Breeding” includes all methods of developing or propagating plants and includes both intra- and inter-species and into- and inter-line crosses as well as all suitable conventional breeding and artificial breeding techniques. Desired traits (e.g., the OME0001 DHA trait) may be transferred to other canola or B. napus lines, cultivars, or cultigens; or through conventional breeding methods and can also be transferred to other Brassica species,
such as B. rapa, through inter-specific crossing. Both conventional breeding methods and inter specific crossing methods, as well as other methods of transferring genetic material between plants, are well-known in the art. For pure line selection, the progeny of single plant selections (self-pollinated), are kept separate and not bulked together. The expected result is a set of genetically homogeneous lines. Accordingly, a pure line may be the progeny of a single self- fertilized homozygous plant.
[0018] “Plant part” includes plant cells, plant organs, plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clumps, and plant cells that are intact in plants or parts of plants such as embryos, pollen, ovules, seeds, pods, leaves, flowers, branches, fruit, stalks, roots, root tips, anthers, cotyledons, hypocotyls, radicles, single cells, gametes, cell cultures, tissue cultures, and the like. A cotyledon is a type of seed leaf; a small leaf contained on a plant embryo. A cotyledon contains the food storage tissues of the seed. The embryo is a small plant contained within a mature seed. “Plant cells” also encompasses non- regenerable plant cells. Accordingly, the embodiments include plants and plant parts from line OMEOOOl line, as well as other plants produced by the described methods. Progeny, derivatives, variants, and mutants of regenerated plants are also included within the scope of the present embodiments, provided that these parts comprise event OMEOOOl nucleic acid molecules. The present embodiments are also directed to line OMEOOOl transgenes, and to their use, e.g., in plant cell culture and tissue culture, and for methods of identifying line OMEOOO 1. The embodiments include plants and plant parts from the elite event OMEOOO 1 line, as well as other plants produced by the described methods. Progeny, derivatives, variants, and mutants of regenerated plants are also included within the scope of the present embodiments, provided that these parts comprise event OMEOOOl nucleic acid molecules.
[0019] At least one embodiment described herein provides a new B. napus line, designated OMEOOOl (DHA Canola OMEOOOl), that produces DHA in its seed oil. Other aspects of the present embodiments provide seed, plants, and plant parts of DHA Canola OMEOOOl; progeny of OMEOOOl; methods for producing a canola plant produced by crossing the DHA Canola OMEOOOl with itself or another canola genotype; and the creation of variants by mutagenesis or transformation of DHA Canola OMEOOOl. Thus, the present embodiments include any such methods using the line OMEOOOl, including selfing, backcrossing, hybrid production, and crosses to populations. All plants produced using line OMEOOOl as a parent are within the scope of the present embodiments. In at least one embodiment, DHA Canola OMEOOOl is used in crosses with other different canola plants to produce first generation (Fi) hybrid seeds and plants with superior characteristics. Accordingly, in addition to B. napus, examples of members of the Brassica genus useful in practicing the present embodiments
include but are not limited to B. napus, B. napobrassica, B. oleracea, B. carinata, B. rapa,
B. juncea, and B. campestris, as well as any other plants belonging to the genus Brassica that permit breeding between Brassica species. Generally, “oilseed plant” refers to any one of the species B. napus, B. rapa (or campestris), or B. juncea.
[0020] DHA Canola OMEOOOl is open pollinated, produces medium to tall sized plants, flowers mid-season, and matures early. Plants have high early plant vigor, are branched, and produce long pods. The seed of OMEOOOl contains co3 LC PUFA including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) characteristic of the Omega 3 NS-B500274 trait, and low saturated and erucic fatty acid content, and low glucosinolate content characteristic of Canola.
[0021] Phenotypic characterizations of DHA Canola OMEOOOl, in addition to production of DHA in seed oil, include:
[0022] In one embodiment, the DHA Canola OMEOOOl provided herein is a B-line. Alternatively, DHA Canola derived from OMEOOOl may be an A-line, a B-line, or a R-line. An A-line is an Ogura cytoplasmic male sterile line (CMS). A B-line is similar to an A-line in all features, but it is a male fertile version (a line of similar nuclear genotype but carrying a male fertile cytoplasm). A R-line (Ogura Rf) carries male sterile cytoplasm but is fixed for a nuclear restorer factors and restores fertility and is used to produce an FI hybrid seed. Because a B-line is used to maintain the fertility it may also be referred to as the maintainer line. A restorer line is a pollinator variety used to pollinate a CMS or A-line to produce FI progeny which are male fertile and thus produce seeds on selfing. An inbred line may permit restoration of fertility to the progeny of male sterile lines to which it is crossed. Thus, hybrid lines may be grown from FI seed produced by crossing two inbred (pure) lines, one of which may be male sterile. OMEOOOl, being a B-line, can be grown as an open pollinated variety or used in the Ogura system to produce FI hybrid variety.
[0023] Accordingly, the present embodiments provide a method of introducing a desired trait into DHA Canola line OMEOOOl, wherein the method comprises crossing an OMEOOOl plant with a plant of another Brassica genotype that comprises a desired trait to produce progeny plants, wherein the desired trait is selected from the group consisting of male sterility, herbicide tolerance, insect resistance, modified fatty acid metabolism, modified carbohydrate metabolism, modified seed yield, modified oil percent, modified protein percent, modified lodging resistance, and resistance to bacterial disease, fungal disease, or viral disease; selecting one or more progeny plants that have the desired trait to produce selected progeny plants; crossing the selected progeny plants with the OMEOOOl plants to produce backcross progeny plants; selecting for backcross progeny plants that have the desired trait and essentially all of the physiological and morphological characteristics of the OME0001 line to produce selected backcross progeny plants; and repeating these steps three or more times to produce selected fourth or higher backcross progeny plants that comprise the desired trait and essentially all of the physiological and morphological characteristics of line OMEOOOl as described herein. Included in this aspect of the embodiments is the plant produced by the method wherein the plant has the desired trait (i.e., DHA production) and essentially all the physiological and morphological characteristics of line OME0001.
[0024] Line OMEOOOl was bred from parental line B. napus, NS-B50027-4, which was developed by Agrobacterium tumefaciens -mediated transformation with the genetic construct pJP3416_GA7-modB (“modB”), that includes seven genes capable of promoting the accumulation of co3 fatty acids in seed. See Petrie et al., Development of a Brassica napus (Canola) Crop Containing Fish Oil-Like Levels ofDHA in the Seed Oil, 11 Frontiers Plant Sci. 727 (2020); U.S. Patents No. 9,718,759 and No. 9,932,541. Briefly, the modB construct contains genes encoding a Dό-dcsaturasc cloned from the microalga Micromonas pusilla, a Dό-elongase and a A5-elongase cloned from the microalga Pyramimonas cordata, a A5-desaturase cloned from the microalga Pavlova salina, a D 15/o)3-desaturase cloned from the yeast Pichia pastoris, a D 12-desaturase cloned from the yeast Lachancea kluyveri, and a A4-desaturase cloned from Pavlova salina, each with suitable transcription promoters and terminators to provide expression in seed. See, e.g., WO 2017/219006. An intensive breeding and selection program resulted in a DHA canola line designated NS-B50027-4, (see U.S. Patents No. 10,570,405 and No. 10,563,218).
[0025] Line OMEOOOl was bred from an advanced breeding line NX 140, a parental line developed by Nuseed via a pedigree and recurrent selection based breeding program that included a complex crossing using Nuseed Canola Genetic Resources and targeted selection strategy using field nurseries to combine: high grain yield potential, traits that provide general agronomic adaptation (e.g., spring type canola, aerial branching habit, and pod set characteristics), blackleg disease resistance, and a canola quality seed oil profile.
[0026] The DHA canola line OME0001 was derived from a marker assisted backcross (BC) program were the “final cross” was from the third cross between NX0140 and NS-B50027-4. BC3F2 generation plants homozygous for NS-B50027-4 event construct inserts were identified using molecular markers. OMEOOOl was derived from BC3F2 seed from and individual F2 plant. Reselection was undertaken in the glasshouse and in single row progeny experimental trials to F4 generation. At each cycle, single plant selections were bagged with a perforated plastic bag prior to flowering and then selfed. At each cycle of reselection, the optimal sib genotypes were advanced on the basis of fatty acid profile (e.g., LC PUFA %, specifically DHA% as a % of total fatty acids in the seed), agronomic traits (e.g., vigor, fertility, standability, blackleg disease tolerance, oil content, maturity, flowering time, plant and pod structures) and other seed quality traits (e.g., seed oil %). The BC3-derived F4 selection was tested in replicated field experiments from 2018 for grain yield, agronomic traits, fatty acid profile, and seed oil traits (e.g., seed oil%). Based on this assessment, the selection was advanced for analysis as a potential commercial cultivar in the United States. OMEOOOl is thus a transgenic Brassica that is genetically stable, uniform, and no off-type plants have been
exhibited in evaluation. The OMEOOOl line has shown genetic stability and uniformity as described in the phenotypic description information. The line has been increased with continued observation for uniformity. Accordingly, an embodiment provides a seed of B. napus line designated OMEOOOl, a representative sample of seed of which was deposited under ATCC Accession No. PTA-126906.
[0027] The primary phenotypic characteristic of OMEOOO 1 is the production of noticeable amounts of DHA in its seed oil. As shown herein, the bulk seed of OMEOOOl typically contains about 7.5% DHA (as % of total fatty acids in seed), or more.
[0028] At least one embodiment is directed to methods for producing a DHA Canola Brassica plant by crossing a first parent plant with a second parent plant, wherein the first or second plant is the plant from the Brassica line OMEOOO 1. In at least one embodiment, both first and second parent plants may be from the line OMEOOO 1. Any breeding methods using the line OMEOOOl are envisioned: selfing, backcrosses, hybrid breeding, and crosses to populations.
Any plants produced using line OMEOOO 1 as a parent are within the scope of the present embodiments.
[0029] Additional methods of the present embodiments include introduction of expression vectors introduced into plant tissues using a direct gene transfer method such as microprojectile-mediated delivery, DNA injection, electroporation or by using Agrobacterium- mediated transformation. In some embodiments, a transgenic variant of OMEOOOl may contain at least one additional transgene (in addition to those present in OMEOOOl), such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 additional transgenes. Accordingly, the present invention also relates to super- transformed variants of the claimed line OMEOOOl, or variants obtained by breeding OMEOOOl with one or more other transgenic Brassica. Such transgenes are expressed under control of regulatory sequences (e.g., promoters, enhancers, intervening sequences, terminators) well- known in the art. In one embodiment, the desired trait may be one or more of herbicide tolerance, insect resistance, disease resistance, modified seed yield, modified oil percent, modified protein percent, modified lodging resistance, or modified fatty acid or carbohydrate metabolism. The specific gene may be any gene known in the art or listed herein, including but not limited to a marker gene, a polynucleotide (nucleic acid molecule) conferring resistance or tolerance to imidazolinone, sulfonylurea, glyphosate, glufosinate, 2,4-D, Dicamba, L- phosphinothricin, triazine, hydroxyphenylpyruvate dioxygenase inhibitor, protoporphyrinogen oxidase inhibitor, phenoxy proprionic acid, cyclohexone, or benzonitrile; a polynucleotide encoding a Bacillus thuringiensis polypeptide, a polynucleotide encoding phytase, a polynucleotide encoding a 1 -acyl-glycerol-3 -phosphate acyltransferase (LPAAT), a galactinol synthase, or a raffmose synthetic enzyme; or a polynucleotide conferring resistance to blackleg,
white rust, or other common canola diseases. Such transgenes and related techniques are well- known in the art, see, e.g.. U.S. Patents No. 9,718,759, No. 8,143,488. Alternatively, the DHA trait of such transgenic embodiments may be obtained by breeding a canola comprising at least one transgene with OMEOOO 1. For example, the trait of producing DPA as well as DHA may be obtained by introgressing chromosomes from DPA JunceaNUBJ1207 (see W02021041570) into OMEOOO 1.
[0030] Accordingly, transgenes or other phenotypic traits can be introduced into OMEOOO 1 or the DHA-producing trait of OMEOOO 1 introduced into other Brassica or canola lines using traditional breeding techniques, such as introgression or backcrossing, well-known in the art. Canola plant breeding techniques that may be employed in generating progeny of OMEOOO 1 include, for example, recurrent selection, bulk selection, mass selection, mutation breeding, backcrossing, pedigree breeding, tissue culture, open pollination breeding, restriction fragment length polymorphism enhanced selection, genetic marker enhanced selection, producing doubled haploids. Often combinations of these techniques are used. The development of Brassica varieties in a plant breeding program requires, in general, the development and evaluation of homozygous varieties. See, e.g., U.S. Patents No. 10,570,405, No. 10,563,218, and No. 8,143,488; Downey et ah, Rapeseed & Mustard, at 437 in PRINCIPLES OF CULTIVAR DEVEL. (Fehr (ed.), Macmillan & Co., NY, 1987); Thompson, Breeding winter oilseed rape Brassica napus, 7 Adv. Appl. Biol. 1-104 (1983); Ward et ah, Oilseed Rape (Farming Press Ltd., Wharefedale Road, Ipswich, Suffolk, 1985).
[0031] In another aspect of the present embodiments, OMEOOO 1 and its progeny can be identified not only by its phenotypic trait (i.e., production of DHA), but by identification of its genotype. Methods and kits are useful for identifying in biological samples the presence of plant material comprising specifically the transgenes in DHA Canola OMEOOO 1, as well as transgenic Brassica plants, plant materials, and seeds containing such event. The elite event DHA Canola OMEOOO 1 described herein can be identified by genotype, which can be characterized through a genetic marker profile that can identify plants of the same cultivar or a related cultivar or be used to determine or validate a pedigree. Genetic marker profiles can be obtained by techniques such as Restriction Fragment Length Polymorphisms (RFLP), Randomly Amplified Polymorphic DNAs (RAPD), Arbitrarily Primed Polymerase Chain Reaction (AP-PCR), DNA Amplification Fingerprinting (DAF), Sequence Characterized Amplified Regions (SCAR), Amplified Fragment Length Polymorphisms (AFLP), Simple Sequence Repeats (SSR) (also referred to as Microsatellites), and Single Nucleotide Polymorphisms (SNP).
[0032] For example, the DHA Canola OMEOOO 1 described herein can be identified by generation of a genetic map from a sample of plant material. A genetic map can be generated by
conventional RFLP, Polymerase Chain Reaction (PCR) analysis, or SSR which identifies the approximate chromosomal location of the integrated DNA molecule coding for the foreign protein. See Glick & Thompson, METHODS IN PLANT MOLEC. BIOL. & BIOTECHNOL. (CRC Press, Boca Raton, 1993). Map information concerning chromosomal location is useful for proprietary protection of a subject transgenic plant. For example, the map of the integration region can be compared to similar maps for suspect plants to determine if the latter have a common parentage with the subject plant. Map comparisons can involve hybridizations, RFLP, PCR, SSR and sequencing, all of which are conventional techniques.
[0033] For identification of DEIA Canola OMEOOO 1 , primers to identify the junctions can be any suitable length derived from a larger junction sequence. The length of the junction sequences used to identify DEIA Canola OMEOOO 1 may be any suitable length that provides identification of a unique junction. These sequences are described for the parent donor of the transgenes required for DEIA synthesis, NS-B50027-4 in, for example, U.S. Patents No. 10,570,405 and No. 10,563,218. Further markers useful for the identification of this trait may be found in PCT/ US2019/050243 and U.S. Appl. No. 17/198,064.
[0034] Canola is recognized as an increasingly important oilseed crop and a source of meal in many parts of the world. DEIA Canola line OMEOOO 1 or its progeny can be used in the production of oil, meal, or other food or feed products in accordance with known techniques.
[0035] In accordance with the Budapest Treaty, Applicants have deposited seed of DHA B. napus OMEOOO 1 with the American Type Culture Collection (ATCC®) located at 10801 University Blvd., Manassas, Va., 20110-2209 U.S.A., under Accession No. PTA-126906. Applicants have satisfied the requirements of 37 C.F.R. §§ 1.801-1.809. Applicants have no authority to waive any restrictions imposed by law on the transfer of biological material or its transportation in commerce. Applicants do not waive any rights granted under patent laws or plant breeders’ rights.
EXAMPLES
Example 1. Cultivation trials, Australia
[0036] DHA Canola OMEOOO 1 was field trialed in replicated plot experiments in 2018, in the South West (Location A) and Wimmera (location B) cereal and broadleaf cropping zones of Victoria, Australia. These cropping zones are characterized by autumn sowing, winter dominant rainfall (i.e., Mediterranean-like) and basalt based acid sodosols for location A, and clay black cracking alkaline vertosols soils for location B. Seed obtained from OMEOOO 1 had the following fatty acid profile as determined by gas chromatography (Table 2):
[0037] Additional data on oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 3 :
[0038] The fatty acid content profde of line OME0001 seed oil was also compared with that of parent NS-B50027-4 and commercial lines, Nuseed Diamond and Nuseed Quartz, grown in other plots in these two Australian trials. The data was averaged and is presented in Table 4:
Example 2. Cultivation trials (Canada)
[0039] DHA-producing B. napus line OMEOOO 1 was grown at two test sites in Canada in 2018, in Canadian plant hardiness zone 3A (Saskatchewan); and the data on oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 5:
Example 3. Cultivation trials (Australia)
[0040] B. napus line OMEOOO 1 was grown in Australian plot experiments in 2019, in two locations in the Wimmera cropping zone described above. Seed obtained from OMEOOO 1 had the following fatty acid profde as determined by gas chromatography as shown in Table 6:
[0041] Further, for one location of the Australian 2019 trial, line OMEOOO 1 pooled seed contained 7.88% total saturated fatty acid. Additional data on yield, oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 7 :
[0042] The fatty acid content profile of DHA canola line OMEOOO 1 was also compared with that of parent NS-B50027-4 and Nuseed commercial cultivars, Nuseed Diamond and Nuseed Quartz, grown as comparators in these two Australian field trials. The data for the two locations were averaged and are presented in Table 8:
Example 5. Cultivation in Canada
[0043] DHA-producing B. napus line OMEOOO 1 was field tested at two sites in Canada in 2019, and the data on grain yield, oil yield, seed protein, meal protein, and glucosinolates from the two trials are shown in Table 9:
Example 6. Cultivation in the North America
[0044] DHA-producing B. napus line OMEOOO 1 was field trialed with comparators at two sites in Canada (Site A, zones 3a; and Site B, zones 3b, respectively) and two sites in the United States (C and D, each zone 4a) in 2019. The mean grain yield across all four sites
was 2.10 t/ha. The amount of DHA (as area %) produced by DHA Canola OMEOOO 1 ranged from 5.5% DHA to 8.6% DHA, and the mean across the sites was 7.0% DHA. Further yield at the two Canadian sites is shown in Table 10:
[0045] The faty acid content for DHA Canola OMEOOO 1 tested at Canadian Site A and
[0046] The North American trials included comparator plots growing B. napus line NS-B50027-4 and commercial varieties Nuseed Diamond and Nuseed Quartz. Data from one of the two Canadian sites are presented in Table 12:
Example 4. Field trials in North America and Australia
[0047] DHA-producing B. napus line OMEOOO 1 was field trialed with comparators at two sites in the United States (Sites E and F), one site in Canada (Site G), and two sites in Australia (Sites H and I) in 2020. The seed content for the 2020 experiment are presented in Table 13.
Example 5. Field trials in North America and Australia
[0048] DHA-producing B. napus line OMEOOOl was field trialed with NS-B50027-4 as a comparator at four sites in Canada (Sites J, K, L, and M), one site in the United States (Site N), and two sites in Australia (Sites O and P) in 2021. The seed content data for the 2021 experiments are presented in Table 14 (nm = not measured):
[0049] Although the preceding embodiments have been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be clear to one of skill in the art that certain changes and modifications, such as single gene modifications and mutations, somaclonal variants, variant individuals selected from large populations of the plants of the instant inbred line, and the like, may be practiced within the scope of the invention which is limited solely by the appended claims.
Claims
1. A seed of transgenic Brassica napus line designated OMEOOOl, a representative sample of seed of which was deposited under ATCC Accession No. PTA- 126906.
2. A transgenic Brassica plant, or part thereof, comprising the genome of the seed of claim 1, produced by growing the seed of claim 1.
3. Pollen of the transgenic plant of claim 2.
4. An ovule of the transgenic plant of claim 2.
5. A transgenic Brassica plant, or parts thereof, having all the physiological and morphological characteristics of the plant of claim 2.
6. A tissue culture of regenerable cells produced from the Brassica plant of claim 2.
7. A tissue culture according to claim 6, the cells or protoplasts being of a tissue selected from the group consisting of leaves, pollen, embryos, roots, root tips, pods, flowers, ovules, and stalks.
8. A tissue culture of regenerable cells of the Brassica plant according to claim 2, wherein the tissue regenerates plants capable of expressing all the morphological and physiological characteristics of the plant according to claim 2.
9. A method of producing Brassica seed, comprising growing the plant of claim 2 to produce seed and harvesting said seed.
10. The method of claim 9, wherein said growing is done in a greenhouse.
11. The method of claim 9, wherein said growing is done in a tent.
12. The method of claim 9, wherein said growing is done in an open field.
13. A method of producing oil, comprising obtaining seed of the plant of claim 2 and processing the seed to obtain oil.
14. The Brassica plant, or parts thereof, of claim 5, wherein the plant or parts thereof have been transformed so that its genetic material contains one or more trans genes, operably linked to one or more regulatory elements, in addition to the transgenes present in B. napus line OMEOOOl.
15. A method for producing a Brassica plant that contains in its genetic material at least one transgene in addition to the transgenes of line OMEOOOl, comprising crossing the plant of claim 14 with either a second plant of another Brassica line, or a plant of line OMEOOOl, so that the genetic material of the progeny that result from the cross expresses the additional at least one transgene.
16. The method of claim 15, wherein the additional transgene confers herbicide tolerance, insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, or sterility.
17. The Bras sica plant, or parts thereof, of claim 5, wherein the plant or parts thereof is the product of traditional breeding techniques and has not been modified by recombinant, mutagenic or other genetic modification other than the elite event associated with OMEOOO 1.
18. A method for producing a Bras sica plant disposed with at least one desired trait in addition to the trait of inbred Bras sica line OMEOOO 1, comprising crossing the plant of claim 17 with either a plant of another Bras sica line, or a plant of inbred line OMEOOO 1 , so that the genetic material of progeny that result from the cross expresses the desired additional trait.
19. The method of claim 18, wherein the additional transgene confers herbicide tolerance, insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, or sterility.
20. A method for producing a Bras sica line OMEOOO 1 -derived canola plant comprising:
(a) crossing Bras sica napus line OMEOOO 1 with a second canola plant to yield progeny canola seed; and
(b) growing said progeny canola seed, under plant growth conditions, to yield said Bras sica line OMEOOO 1 -derived canola plant.
21. The method of claim 20, further comprising:
(c) crossing said OMEOOO 1 -derived canola plant with itself or another canola plant to yield additional OMEOOO 1 -derived progeny canola seed;
(d) growing said progeny canola seed of step (a) under plant growth conditions, to yield additional OMEOOO 1 -derived canola plants; and
(e) repeating the crossing and growing steps of (a) and (b) from zero (0) to seven (7) times to generate further OMEOOO 1 -derived canola plants, wherein said OMEOOO 1 -derived canola plants express least two OMEOOO 1 -traits selected from DHA production and at least one additional agronomically desirable trait.
22. A Bras sica line OMEOOO 1 -derived canola plant, or parts thereof, produced by the method of claim 20.
23. A canola OMEOOO 1 -derived canola plant, or parts thereof, produced by the method of claim 21.
24. A method for producing Bras sica seed comprising crossing a first parent Bras sica plant with a second parent Brassica plant and harvesting the resultant first generation Brassica seed, wherein said first or second parent Brassica plant is the Brassica plant of claim 2.
25. The method according to claim 24, wherein said first parent Brassica plant is different from said second parent Brassica plant, and wherein said resultant seed is a first generation (FI) hybrid Brassica seed.
26. A method for obtaining a canola inbred line comprising:
(a) planting a collection of seed comprising seed of a hybrid, one of whose parent is the Brassica plant according to claim 2, said collection also comprising seed of said inbred line;
(b) growing canola plants from said collection of seeds;
(c) identifying an inbred plant from said inbred line;
(d) selecting said inbred plant; and
(e) controlling pollination in a manner that preserves the homozygosity of said inbred plant.
27. The method according to claim 26, wherein said one parent has all the physiological and morphological characteristics of inbred Brassica line OMEOOOl, seed of said line having been deposited under ATCC Accession No. PTA- 126906
28. The method of claim 24, wherein the canola inbred line is B. napus or B. juncea.
29. A cell of Brassica napus line OMEOOOl, representative sample of seed of which was deposited under ATCC accession number PTA- 126906.
30. Genomic DNA of inbred canola line OMEOOOl, representative seed of said inbred canola line having been deposited under ATCC Accession Number PTA- 126906.
31. A seed of OMEOOOl comprising about 8%, about 9%, about 10%, about 11 %, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, or about 20%, inclusive, DHA (as % of total fatty acid in seed oil).
32. A collection of seed comprising at least 95% seed of Brassica napus line OMEOOOl, wherein said seed comprises about 8%, about 9%, about 10%, about 11 %, about 12%, about 13%, about 14%, about 15%, about 16%, about 17%, about 18%, about 19%, or about 20%, inclusive, DHA + EPA + DPA (as % of total fatty acids in seed oil).
33. A method of obtaining DHA-containing canola grain comprising the steps of
(a) introgressing the DHA trait of OMEOOOl (deposited under ATCC Accession Number PTA-126906) into an elite Brassica line that is male sterile;
(b) introgressing the DHA trait of OmeOOOl into a second elite Brassica line that is fertile;
(c) crossing the two lines (a) and (b) to obtain a hybrid progeny;
(d) cultivating the seed of the hybrid progeny; and
(e) harvesting the grain produced by the cultivated hybrid progeny.
34. The method of claim 33, wherein said hybrid progeny comprises at least one trait selected from herbicide tolerance, insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, or sterility.
35. A method of producing docosahexaenoic acid (DHA) -containing canola oil, comprising processing seed from transgenic Brassica napus line designated OMEOOO 1 or its progeny, representative sample of seed of which was deposited under ATCC Accession No. PTA-126906, to obtain DHA-canola oil.
36. A method of producing a seed oil comprising docosahexaenoic acid (DHA), said method comprising the steps of:
(a) obtaining the seed of the transgenic Brassica napus line designated OMEOOO 1 or its progeny, representative sample of seed of which was deposited under ATCC Accession
No. PTA-126906, and
(b) extracting the seed oil from said seed.
37. The method of claim 36, further comprising incorporating said seed oil into a foodstuff for human consumption.
38. The method of claim 37, wherein said foodstuff is cooking oil or salad oil
39. The method of claim 36, further comprising incorporating said seed oil into a foodstuff for animal consumption.
40. The method of claim 39, wherein said foodstuff is an aquaculture feed.
41. The method of claim 36, further comprising incorporating said seed oil into a nutritional supplement.
42. The method of claim 41, further comprising the steps of refining said seed oil and incorporating said refined seed oil into a nutritional supplement.
43. A method of producing a seed meal obtained from seeds of the transgenic Brassica napus line designated OMEOOO 1 or its progeny, representative sample of seed of which was deposited under ATCC Accession No. PTA-126906, said method comprises,
(a) crushing the seeds of said transgenic Brassica napus line designated OMEOOO 1 or its progeny;
(b) extracting the oil from the crushed seeds; and
(c) obtaining the seed meal from the crushed seeds.
44. The method of claim 43, further comprising processing the seed meal into foodstuff for animal consumption.
45. The method of claim 44, wherein said foodstuff is aquaculture feed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163176991P | 2021-04-20 | 2021-04-20 | |
US63/176,991 | 2021-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022224146A1 true WO2022224146A1 (en) | 2022-10-27 |
Family
ID=83722723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/053662 WO2022224146A1 (en) | 2021-04-20 | 2022-04-19 | Brassica napus line ome0001 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022224146A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017219006A1 (en) * | 2016-06-16 | 2017-12-21 | Nuseed Pty Ltd. | Elite event canola ns-b50027-4 |
WO2017218969A1 (en) * | 2016-06-16 | 2017-12-21 | Nuseed Pty Ltd. | Inbred transgenic canola line ns-b50027-4 and seeds thereof |
-
2022
- 2022-04-19 WO PCT/IB2022/053662 patent/WO2022224146A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017219006A1 (en) * | 2016-06-16 | 2017-12-21 | Nuseed Pty Ltd. | Elite event canola ns-b50027-4 |
WO2017218969A1 (en) * | 2016-06-16 | 2017-12-21 | Nuseed Pty Ltd. | Inbred transgenic canola line ns-b50027-4 and seeds thereof |
Non-Patent Citations (1)
Title |
---|
PETRIE JAMES R., ZHOU XUE-RONG, LEONFORTE ANTONIO, MCALLISTER JASON, SHRESTHA PUSHKAR, KENNEDY YOKO, BELIDE SRINIVAS, BUZZA GREG, : "Development of a Brassica napus (Canola) Crop Containing Fish Oil-Like Levels of DHA in the Seed Oil", FRONTIERS IN PLANT SCIENCE, vol. 11, XP055890862, DOI: 10.3389/fpls.2020.00727 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6392127B1 (en) | Oilseed Brassica containing an improved fertility restorer gene for ogura cytoplasmic male sterility | |
AU2012251933B2 (en) | Cotton variety PHY499WRF | |
US20060225156A1 (en) | Canola variety SW 013186 | |
US20060225158A1 (en) | Canola variety SW 013062 | |
US20060225157A1 (en) | Canola variety SW 013154 | |
AU2014271250A1 (en) | Cotton variety PHY495W3RF | |
AU2015271954B2 (en) | Cotton variety PX499-36W3RF | |
AU2012251929B2 (en) | Cotton variety P04X.3074 | |
AU2011244847B2 (en) | Cotton variety 99M-548 | |
AU2008321081B2 (en) | Brassica juncea lines with a canola fatty acid profile | |
CA2883230A1 (en) | Soybean variety 01050493 | |
WO2022224146A1 (en) | Brassica napus line ome0001 | |
CN114599224B (en) | Mustard line NUBJ1207 | |
US10455792B2 (en) | Soybean cultivar TMG4177 | |
CA2924434C (en) | Soybean variety xr33au15x | |
CA2924371C (en) | Soybean variety xr25al15x | |
CA2924433C (en) | Soybean variety xr23aq15x | |
CA2924374C (en) | Soybean variety xr09al15x | |
CA2883237C (en) | Soybean variety 01057523 | |
AU2021200587A1 (en) | Cotton variety 11PWAQ90 | |
AU2021200586A1 (en) | Cotton variety 11PYKG43 | |
AU2021200585A1 (en) | Cotton variety 11PSGN85 | |
AU2020201018A1 (en) | Cotton variety PX3B07W3FE | |
AU2020201025A1 (en) | Cotton variety PX3C06W3FE | |
CA2883233A1 (en) | Soybean variety 01050906 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22791219 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |